KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Shares IssuedShares OutstandingShares Outstanding
Ratios

Vir Biotechnology (VIR) Leases (2020 - 2025)

Vir Biotechnology's Leases history spans 6 years, with the latest figure at $62.1 million for Q4 2025.

  • On a quarterly basis, Leases rose 4.05% to $62.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $62.1 million, a 4.05% increase, with the full-year FY2025 number at $62.1 million, up 4.05% from a year prior.
  • Leases hit $62.1 million in Q4 2025 for Vir Biotechnology, down from $63.6 million in the prior quarter.
  • Over the last five years, Leases for VIR hit a ceiling of $88.3 million in Q1 2022 and a floor of $57.6 million in Q3 2021.
  • Historically, Leases has averaged $70.5 million across 5 years, with a median of $67.6 million in 2024.
  • Biggest five-year swings in Leases: soared 289.96% in 2021 and later dropped 16.91% in 2024.
  • Tracing VIR's Leases over 5 years: stood at $87.2 million in 2021, then fell by 5.35% to $82.6 million in 2022, then fell by 13.78% to $71.2 million in 2023, then decreased by 16.16% to $59.7 million in 2024, then increased by 4.05% to $62.1 million in 2025.
  • Business Quant data shows Leases for VIR at $62.1 million in Q4 2025, $63.6 million in Q3 2025, and $64.9 million in Q2 2025.